Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,427 signal articles · 132 in last 24h · 153,916 total before filter · latest 1h ago
132last 24h
864last 7d
142● bullish (7d)
100● bearish (7d)
214publishers
AllMacro207Earnings103M&A123Regulatory22Product21Analyst14
✕ clear all filtersticker: WSTSentiment:bullishneutralbearishshow all (incl. clickbait)
West Pharmaceutical Services Q2 Earnings Call Highlights
MarketBeat62d agoneutral
West Pharmaceutical Services Q2 Earnings Call Highlights

West Pharmaceutical Services (NYSE:WST) raised its full-year 2026 outlook after reporting second-quarter results that topped management’s expectations, supported by strong demand for high-value product components, biologics-related offerings and GLP-1 elastomers. Chief Executive Officer and Board C

West Pharmaceutical Services (NYSE:WST) Beats Expectations in Strong Q2 CY2026, Stock Soars
StockStory63d agobullish
West Pharmaceutical Services (NYSE:WST) Beats Expectations in Strong Q2 CY2026, Stock Soars

Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 13.8% year on year to $872.3 million. Guidance for next quarter’s revenue was better than expected at $827.5 million at the midpoint, 0.8% above analysts’ estimates. Its non-GAAP profit of $2.37 per share was 13.9% above analysts’ consensus estimates.